A new perspective article in Frontiers in Psychiatry argues that circadian rhythm dysfunction is a clinically significant and highly prevalent phenotype in a substantial subgroup of people with Attention-Deficit/Hyperactivity Disorder (ADHD). The authors synthesize evidence linking ADHD with evening chronotype and phase-delayed biological markers. Insomnia and sleep disturbances affect up to 80% of adults with ADHD and up to 82% of children with ADHD, while delayed sleep-wake timing occurs in up to 78% of cases. Dim-light melatonin onset (DLMO) is delayed by roughly 45 minutes in children and 90 minutes in adults. These alterations coincide with blunted and delayed cortisol rhythms, reduced pineal volume, and attenuated peripheral clock-gene rhythms.
Intervention studies suggest the circadian phase can be advanced in ADHD populations. Melatonin and bright light therapy have shifted DLMO earlier in both children and adults with ADHD. Emerging data correlate this phase advancement with improvements in ADHD symptoms, and winter trials indicate that shifts in circadian preference best predict symptom improvement. Sleep programs have also improved ADHD symptoms, sleep quality, and functioning in children.
Based on this evidence, the authors propose a behavioral-first clinical pathway. It includes routine screening for sleep and circadian disturbances, chronotype assessment and sleep tracking, fixed wake times, morning bright light exposure, evening light restriction, and selective low-dose melatonin for confirmed or probable DLMO delays. The authors describe these behavioral circadian interventions as pragmatic, scalable and generally low risk.
The authors call for rigorous, stratified trials to quantify effects on core ADHD outcomes, define responder phenotypes and optimize circadian-focused protocols.
Source: Hacker News · Summarized by HeadlinesBriefing